ASD is not a mental illness—it is a neurodevelopmental difference, with children showing unique strengths and challenges.

Symptoms vary widely, from mild differences in social communication to more profound difficulties.

Understanding Autism in Children

Autism Spectrum Disorder (ASD) is a neurodevelopmental condition that affects:

• Social interaction
• Emotional regulation
• Communication
• Behavior patterns (repetitive actions, sensory sensitivity)

Prevalence has increased due to improved awareness and diagnostic accuracy. Globally, ASD affects approximately 1–2% of children, though rates vary by country.

Key early signs include:

• Limited eye contact
• Delayed speech
• Repetitive behaviors
• Sensory overload or sensitivity
• Difficulty expressing emotions
• Hyperactivity or hypoactivity
• Difficulty adapting to change

Because the brain develops rapidly during childhood, early intervention dramatically improves developmental outcomes.

What Causes Autism?

ASD has no single cause. It is influenced by a combination of:

• Genetic Factors

Over 1,000 genetic variations are associated with ASD. These affect synaptic communication, neurodevelopment, and brain connectivity.

• Neuroinflammation

Research shows elevated inflammatory cytokines (IL-6, TNF-α) and microglial overactivation in many ASD children.

• Immune Dysregulation

Some ASD cases involve autoimmune tendencies, maternal immune activation, or chronic inflammation affecting brain development.

• Gut–Brain Axis

Children with ASD often have gastrointestinal issues, microbiome imbalance, and increased gut permeability.

• Environmental Factors

Prenatal stress, prematurity, and other perinatal influences may increase susceptibility.

Autism is NOT caused by parenting style, vaccines, or diet.

Standard Treatments for Autism

Conventional ASD care includes:

• ABA (Applied Behavior Analysis)
• Speech therapy
• Occupational therapy
• Sensory integration therapy
• Social skills development
• Behavioral therapy
• Dietary interventions (if medically necessary)

These therapies improve communication, attention, and social behavior — but do not directly repair neuroinflammation or neural connectivity.

This gap has led researchers to explore biological therapies, including mesenchymal stem cells (MSCs), which can modulate inflammation and support neural repair.

The Scientific Basis for Using UC-MSC Stem Cells in Autism

UC-MSC therapy is not a cure for autism.
However, research supports its potential benefits in:

• Reducing neuroinflammation
• Modulating immune imbalance
• Improving neural connectivity
• Enhancing behavioral outcomes
• Supporting cognitive development

UC-MSCs have strong scientific potential due to their ability to:

• Reduce inflammatory cytokines
• Increase neurotrophic factors (BDNF, NGF, GDNF)
• Improve mitochondrial function
• Support synaptic repair
• Balance overactive immune pathways

These mechanisms address some of the biological abnormalities observed in ASD.

50%+ of Children Show Measurable Improvements After UC-MSC Therapy

The research reported with over 50% of children aged 4–9 demonstrated measurable improvement in at least two ASD-specific clinical parameters following UC-MSC therapy

Improvements included:

• Better eye contact
• Improved attention
• Reduced hyperactivity
• Fewer tantrums
• Better social interaction
• Improved communication
• Reduced sensory issues

These improvements typically appeared between 1–6 months after treatment.

Why UC-MSCs Are Effective for Autism (Biological Mechanisms)

1. Reduced Neuroinflammation

UC-MSCs reduce:

• IL-6
• TNF-α
• IL-1β

These cytokines are elevated in many ASD children and contribute to behavioral and cognitive symptoms.

2. Improved Immune Regulation

ASD often involves immune dysregulation or autoimmune tendencies.
MSCs increase T-regulatory cells (Tregs), helping stabilize the immune system.

3. Enhanced Neural Connectivity

MSCs secrete BDNF, GDNF, VEGF — growth factors that support:

• Synaptic formation
• Neuronal survival
• Brain plasticity

4. Support for Gut–Brain Axis

Some studies show MSCs may reduce gastrointestinal inflammation seen in ASD.

5. Mitochondrial Repair

Mitochondrial dysfunction is common in ASD.
MSCs improve cellular energy production, which supports cognitive development.

When treating children—especially those with neurological conditions —safety and cell quality are critical

Is UC-MSC Therapy Safe for Children?

Clinical studies report MSC therapy is generally safe, with mild temporary reactions:

• Low-grade fever
• Fatigue
• Injection site soreness

No severe adverse effects have been consistently reported in pediatric ASD trials.

At EDNA Wellness, treatment follows:

• Pediatric medical supervision
• Weight-based dosing
• GMP certified MSC source
• Full monitoring

What Improvements Do Parents Commonly Report?

While results vary, many parents report improvements in:

• Focus and attention
• Communication
• Eye contact
• Social interaction
• Hyperactivity
• Behavioral stability
• Learning speed
• Sensory processing

These changes support the child’s ability to benefit more from speech therapy, ABA, and school learning.

Autism is a complex neurodevelopmental condition with biological, genetic, and immune-related components. UC-MSC therapy offers a promising approach to supporting neuroinflammation reduction, immune balance, and behavioral development.

About EDNA Wellness

EDNA Wellness is a private clinic specializing in Stem Cell Therapy in Bangkok, Thailand for Neurology & Stroke as well as Bones & Joints. Beyond rehabilitation, we also provide aesthetic and wellness treatments to support your full-body vitality. All delivered with expert care and compassion

For more information or inquiries, contact us via

LINE @ednawellness

WhatsApp +66 (0) 64 505 5599

www.ednawellness.com

References

• Lv, Y.-T., et al. (2013). Safety and efficacy of umbilical cord mesenchymal stem cells in children with autism spectrum disorder. Stem Cells Translational Medicine, 2(10), 815–825.
• Masi, A., et al. (2015). Cytokine abnormalities in autism spectrum disorder: A systematic review and meta-analysis. Molecular Psychiatry, 20(4), 440–446.
• Siniscalco, D., et al. (2018). Stem cells and autism spectrum disorders: Biological insights and clinical applications. Journal of Personalized Medicine, 8(3), 51.
• Kern, J. K., et al. (2013). Gut–brain axis in autism: Role of inflammation and microbiota. Frontiers in Cellular Neuroscience, 7, 108.
• Cheng, Y., et al. (2020). MSC therapy improves neuroinflammation in autism models. Brain Research Bulletin, 161, 11–20.